Skip to main content
AI

AI shortens drug discovery to around 1 year in China: Insilico CEO

Hong Kong-listed Insilico Medicine has cut drug development timelines to about one year by combining AI with its China research ecosystem, its CEO said. Insilico CEO Alex Zhavoronkov told Reuters in an interview at its Shanghai R&D facility that the company's record is nine months to a developmental candidate, with a typical timeline of 13 months. He said it usually takes about 4.5 years to get to a drug developmental candidate using the traditional approach, but having a research lab in China can cut two years of time.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from emirates247.com and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
AI Policy
AI Policy

Report says Inspur uses subsidiaries to obtain advanced AI chips

The New York Times reports that Inspur, a China-owned company blacklisted by Washington over work with the Chinese military, has bypassed US restrictions on advanced AI chips through new subsidiaries and partners. The report says ...

Capital AI
Capital AI

Mistral AI reported to be raising €3 billion Series D round

Mistral AI is raising €3 billion ($3.49 billion) in a Series D round, according to Bloomberg Technology, with Samsung Electronics joining the financing. Chief Executive Arthur Mensch said the French AI company is probably still un...

Capital AI
Capital AI

Cognition reports $2 billion Series E at $48 billion valuation

Cognition AI said it raised more than $2 billion in a Series E financing at a $48 billion valuation. SiliconANGLE reported that the company's prior May round raised more than $1 billion at a $26 billion valuation and that Cogniti...

AI Infrastructure
AI Infrastructure

Anthropic lines up at least 14.8 GW of compute agreements

Anthropic has entered agreements for at least 14.8 GW of compute capacity since October, according to an analysis by The Information summarized by Techmeme. The analysis says the company has made cloud-computing deals with SpaceX,...

AI Capital
AI Capital

Anthropic reportedly declines Decart AI acquisition

Anthropic has decided against acquiring AI startup Decart AI, according to people familiar with the matter, Bloomberg reported. The companies may still explore other ways to collaborate, one of the people said. The report does not...

AI
AI

AWS makes GPT-6 Astra available through Bedrock

Amazon Web Services said GPT-6 Astra is now generally available through Amazon Bedrock APIs. AWS said customers can configure ChatGPT Work and Codex to use the model on Bedrock, while new ChatGPT Work enterprise plugins extend bro...